Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2

NCT05075538 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.

NCT NCT05075538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05075538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2
Lead sponsor
Jules Bordet Institute
Phase
Phase 4
Overall status
Terminated
Start date
December 1, 2021
Completion date
January 8, 2024
Enrollment
152 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer